Name: Cost effectiveness: Summary
Creator: Steven P. Ringel
Keywords: Riluzole, Attitude of Health Personnel, Cost-Benefit Analysis, Amyotrophic Lateral Sclerosis, 01 natural sciences, Resource Allocation, 3. Good health, 03 medical and health sciences, Neuroprotective Agents, 0302 clinical medicine

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2002 English Publisher:Informa UK LimitedJournal:Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, volume 3, pages S67-S69 (issn: 1466-0822,

Authors: Steven P. Ringel;

doi: 10.1080/146608202320374345

pmid: 12396813

Cost effectiveness: Summary

- Summary
- Subjects
- Metrics

Abstract

(2002). Cost effectiveness: Summary. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Vol. 3, No. sup1, pp. S67-S69.

Related Organizations

University of New Mexico Hospital
United States
University of Colorado Cancer Center
United States
University of Colorado Health
United States

Keywords

Riluzole, Attitude of Health Personnel, Cost-Benefit Analysis, Amyotrophic Lateral Sclerosis, Resource Allocation, Neuroprotective Agents, Costs and Cost Analysis, Humans, Health Expenditures

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average